UBS Group
TNMG

UBS Group’s TNL Mediagene TNMG Stock Holding History

UBS Group’s Portfolio TNMG Stock Details TNMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.05K Buy
972
+830
+585% +$6.03K ﹤0.01% 8971
2026
Q1 		$2.09K Sell
142
-250
-64% -$5.56K ﹤0.01% 9363
2025
Q4 		$8.56K Buy
392
+345
+734% +$16.1K ﹤0.01% 8355
2025
Q3 		$1.98K Sell
47
-225
-83% -$14.7K ﹤0.01% 9247
2025
Q2 		$21.3K Buy
272
+252
+1,260% +$21.5K ﹤0.01% 8382
2025
Q1 		$2.48K Buy
20
+5
+33% +$2.03K ﹤0.01% 9324
2024
Q4 		$18.4K Buy
+15
New +$23.1K ﹤0.01% 7932

Other funds holding TNMG

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

UBS Group's TNMG Position: Q2 2026 in Review

UBS Group increased its TNL Mediagene (TNMG) stake by 585% in Q2 2026, buying an estimated $6.03K and bringing the position to 972 shares worth $5.05K. The position accounts for ﹤0.01% of the portfolio, ranked #8971.

UBS Group first reported a position in TNMG in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.3K in Q2 2025. 3 funds tracked by Wall St. Rank hold TNMG as of Q2 2026.

  • UBS Group held 972 shares of TNL Mediagene worth $5.05K as of Q2 2026.
  • UBS Group bought 830 TNL Mediagene shares in Q2 2026, an estimated $6.03K.
  • TNL Mediagene made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8971 holding.
  • UBS Group first reported a position in TNL Mediagene in Q4 2024 and has held it in 7 quarters since.
  • UBS Group's TNL Mediagene position peaked at $21.3K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held TNL Mediagene as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.